Showing results (61-70 of 167) with videos related to

Sort By:
Pageof 17
The Journal of Biological Chemistry|February 13, 2004
Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugsHongjiang Wu, Walt F Lima, Hong Zhang, et al.
Iscience|August 12, 2021
The evolutionary origin of Bayesian heuristics and finite memoryAndrew W Lo, Ruixun Zhang
Proceedings of the National Academy of Sciences of the United States of America|June 26, 2021
The origin of cooperationNihal Koduri, Andrew W Lo
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2022
Hamilton's rule in economic decision-makingMoshe Levy, Andrew W Lo
Contemporary Clinical Trials|September 14, 2017
Re-inventing drug development: A case study of the I-SPY 2 breast cancer clinical trials programSonya Das, Andrew W Lo
Frontiers in Computational Neuroscience|March 13, 2018
Is Smaller Better? A Proposal to Use Bacteria For Neuroscientific ModelingArchana Ram, Andrew W Lo
Nucleic Acids Research|June 6, 2019
mRNA levels can be reduced by antisense oligonucleotides via no-go decay pathwayXue-Hai Liang, Joshua G Nichols, Chih-Wei Hsu, et al.
Biochemical Pharmacology|August 18, 2020
Antisense drug discovery and development technology considered in a pharmacological contextStanley T Crooke, Xue-Hai Liang, Rosanne M Crooke, et al.
Nucleic Acid Therapeutics|February 3, 2021
Solid-Phase Separation of Toxic Phosphorothioate Antisense Oligonucleotide-Protein Nucleolar Aggregates Is CytoprotectiveXue-Hai Liang, Cheryl Li De Hoyos, Wen Shen, et al.
Nature Biotechnology|July 12, 2016
Translation efficiency of mRNAs is increased by antisense oligonucleotides targeting upstream open reading framesXue-Hai Liang, Wen Shen, Hong Sun, et al.
Pageof 17